Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic Dysfunctions
Yubai Zhou(University of North Carolina at Chapel Hill), Xiaodong Wang(University of North Carolina at Chapel Hill), Kenneth H. Pearce(University of North Carolina at Chapel Hill), Anutosh Chakraborty(Scripps Research Institute), Huanchen Wang(National Institute of Environmental Health Sciences), Michael A. Stashko(University of North Carolina at Chapel Hill), Molee Chakraborty(Saint Louis University), Guangning Zong(National Institute of Environmental Health Sciences), Sandip Mukherjee(Saint Louis University), Daowei Huang(University of North Carolina at Chapel Hill), Chunfang Gu(National Institute of Environmental Health Sciences), Stephen B. Shears(National Institute of Environmental Health Sciences)
Cited by 31
Related Papers
Adipocyte-specific deletion of Ip6k1 reduces diet-induced obesity by enhancing AMPK-mediated thermogenesis
|Journal of Clinical Investigation|2016|87
Crystal structures of rhamnosyltransferase <scp>UGT</scp>89C1 from <i>Arabidopsis thaliana</i> reveal the molecular basis of sugar donor specificity for <scp>UDP</scp>‐β‐<scp>l</scp>‐rhamnose and rhamnosylation mechanism
|The Plant Journal|2019|78
Crystal Structures of the <i>C</i>-Glycosyltransferase UGT708C1 from Buckwheat Provide Insights into the Mechanism of <i>C</i>-Glycosylation
|The Plant Cell|2020|51
Synthesis and biological activities of novel 2-amino-1,3-thiazole-4-carboxylic acid derivatives
|Chinese Chemical Letters|2015|31